FDA Calendar

Date PDUFA table FDA is very important, because they help you to watch when decisions on main areas will be announced. In addition, as a rule, such reviews make it possible to anticipate key events and their development. Thus, the presence of prior knowledge of the catalyst provides a way to maximize profits or minimize losses trading in the stock of biotechnology companies.
Date Company Event Description Result
Amicus Therapeutics NDA FILING MIGALASTAT, Fabry disease Failure
Akebia Therapeutics Phase 2 Vadadustat, Anemia related to chronic kidney disease Success
Aerie Pharmaceuticals Phase 3 Rhopressa, Glaucoma & ocular hypertension Success
ADMA Biologics BLA FILING RI-002, immune deficiency diseases Success
1 2